X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/carsgen-announced-2023-annual-results-302100388.html
https://www.prnewswire.com/news-releases/nmpa-approves-the-nda-for-carsgens-bcma-car-t-therapy-zevorcabtagene-autoleucel-for-relapsed-or-refractory-multiple-myeloma-302076758.html
https://www.prnewswire.com/news-releases/carsgens-presents-updated-research-results-on-ct041-at-2024-asco-gi-meeting-302038279.html
https://www.prnewswire.com/news-releases/carsgens-ct011-achieves-ind-clearance-from-the-nmpa-for-the-gpc3-positive-stage-a-hepatocellular-carcinoma-at-high-risk-of-recurrence-after-surgical-resection-302034257.html
https://www.fiercebiotech.com/biotech/fda-puts-car-t-roadblock-slapping-holds-3-carsgen-cell-therapies-after-inspecting-facility
https://www.prnewswire.com/news-releases/carsgen-presents-updated-research-results-on-zevor-cel-at-2023-ash-annual-meeting-302012686.html
https://www.prnewswire.com/news-releases/carsgens-ct071-received-ind-clearance-from-the-fda-for-treating-relapsedrefractory-multiple-myeloma-or-relapsedrefractory-primary-plasma-cell-leukemia-302004156.html
https://www.prnewswire.com/news-releases/carsgens-car-gpc3-t-cell-therapy-for-advanced-hepatocellular-carcinoma-two-patients-achieved-over-7-years-of-disease-free-survival-301954626.html
https://www.prnewswire.com/news-releases/two-cases-of-pancreatic-cancer-treatment-with-carsgens-ct041-published-in-journal-of-hematology--oncology-301934471.html
https://endpts.com/moderna-and-carsgen-partner-on-car-t-cell-therapy-and-cancer-vaccine-combo/
Market Place
Share 
